| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 110K | Jan 31, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | Jan 31, 2025 | 1 | $0 | 4 | Jan 31, 2025 | Chief Financial Officer |
| CTNM | Contineum Therapeutics, Inc. | May 24, 2024 | 1 | $0 | 4 | May 29, 2024 | Chief Financial Officer |
| CTNM | Contineum Therapeutics, Inc. | Apr 4, 2024 | 0 | $0 | 3 | Apr 4, 2024 | Chief Financial Officer |